Superstring Capital Management »

Boundless Bio shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $138k 55k 2.50

More positions owned by Superstring Capital Management

Cogent Biosciences (COGT)
Axsome Therapeutics (AXSM)
Genmab A/s Sponsored Ads (GMAB)
Celldex Therapeutics Com New (CLDX)
Trevi Therapeutics (TRVI)
Revolution Medicines (RVMD)
Definium Therapeutics Com Shs (DFTX)
Vir Biotechnology (VIR)
Immunovant (IMVT)
Urogen Pharma (URGN)
Eliem Therapeutics (CLYM)
Adlai Nortye Sponsored Ads (ANL)
Savara (SVRA)
Maplight Therapeutics (MPLT)
Oric Pharmaceuticals (ORIC)

View all positions for Superstring Capital Management

Top funds holding Boundless Bio

Arch Venture Corp
FMR
Tang Capital Management
ADAR1 Capital Management
Cormorant Asset Management
Vanguard Capital Management
Wellington Management Company
Millennium Management
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Stonepine Capital Management
Acadian Asset Management

View all funds holding Boundless Bio